As of September 30, 2026, Alignment Healthcare, Inc. carries a market capitalization of 1.71B, placing it among publicly traded companies globally. Its enterprise value stands at 1.29B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.71B |
| Enterprise Value | 1.29B |
Alignment Healthcare, Inc.'s next confirmed earnings release is scheduled for March 4, 2027.
| Earnings Date | 3/4/2027 |
As of September 30, 2026, Alignment Healthcare, Inc. has 209.15M shares outstanding.
| Shares Outstanding | 209.15M |
As of September 30, 2026, Alignment Healthcare, Inc. trades at a trailing price-to-earnings ratio of 58.01. The price-to-sales ratio is 0.34, and the price-to-book ratio stands at 6.16.
| PE Ratio | 58.01 |
| PS Ratio | 0.34 |
| PB Ratio | 6.16 |
| P/TBV Ratio | 7.10 |
| P/FCF Ratio | 22.18 |
| P/OCF Ratio | 15.53 |
As of September 30, 2026, Alignment Healthcare, Inc. trades at an EV/EBITDA multiple of 17.21 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.26 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 29.74 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 1.29B versus a market cap of 1.71B, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 0.26 |
| EV / EBITDA | 17.21 |
| EV / EBIT | 29.74 |
As of September 30, 2026, Alignment Healthcare, Inc. maintains a current ratio of 1.71, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 119.34, indicating elevated leverage, while an interest coverage ratio of 4.54 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.71 |
| Quick Ratio | 1.43 |
| Debt / Equity | 119.34 |
| Debt / EBITDA | 4.40 |
| Interest Coverage | 4.54 |
Over the twelve months ended September 30, 2026, Alignment Healthcare, Inc. posted a return on equity (ROE) of 13.17, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 2.41, measuring how efficiently the asset base is converted into earnings. The company generates approximately 2.67M in revenue per employee across its workforce of 1,849.00, a quick read on workforce productivity versus industry peers.
| Return on Equity (ROE) | 13.17 |
| Return on Assets (ROA) | 2.41 |
| Revenue Per Employee | 2.67M |
| Employee Count | 1,849.00 |
Over the twelve months ended September 30, 2026, Alignment Healthcare, Inc. recorded an income tax benefit of -1.96M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. Taxes are levied on pretax income of 26.96M, leaving 28.92M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.
| Income Tax | -1.96M |
As of the close on November 16, 2026, Alignment Healthcare, Inc.'s stock has declined approximately 54.78% over the past 52 weeks. The 50-day moving average sits at 8.54, while the 200-day moving average is 15.97.
| 52-Week Price Change | -54.78% |
| 50-Day Moving Average | 8.54 |
| 200-Day Moving Average | 15.97 |
Over the twelve months ended September 30, 2026, Alignment Healthcare, Inc. generated 4.94B in revenue and converted that into 28.92M in net income, yielding earnings per share of 0.14. EBITDA reached 75.19M, while operating income came in at 43.53M.
| Revenue | 4.94B |
| Gross Profit | 589.43M |
| Operating Income | 43.53M |
| Pretax Income | 26.96M |
| Net Income | 28.92M |
| EBITDA | 75.19M |
| EBIT | 43.53M |
| Earnings Per Share (EPS) | 0.14 |
As of September 30, 2026, Alignment Healthcare, Inc. holds 742.95M in cash and equivalents against 330.70M in total debt, resulting in a net debt position of -403.20M. Total book value stands at 277.11M, with working capital of 489.26M providing operational flexibility.
| Cash & Cash Equivalents | 742.95M |
| Total Debt | 330.70M |
| Net Debt | -403.20M |
| Equity (Book Value) | 277.11M |
| Book Value Per Share | 1.32 |
| Working Capital | 489.26M |
Alignment Healthcare, Inc. produced 108.02M in operating cash flow over the twelve months ended September 30, 2026. After subtracting -30.98M in capital expenditures, free cash flow totaled 77.04M - equivalent to 0.37 per share.
| Operating Cash Flow | 108.02M |
| Capital Expenditures | -30.98M |
| Free Cash Flow | 77.04M |
| FCF Per Share | 0.37 |
Over the twelve months ended September 30, 2026, Alignment Healthcare, Inc. posted a gross margin of 11.93, reflecting its pricing power and cost economics. The operating margin of 0.88 and net profit margin of 0.59 provide insight into operational efficiency.
| Gross Margin | 11.93 |
| Operating Margin | 0.88 |
| Pretax Margin | 0.55 |
| Profit Margin | 0.59 |
| EBITDA Margin | 1.52 |
These figures cover the twelve months ended September 30, 2026. Free cash flow yield stands at 4.51, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -1.24, meaning Alignment Healthcare, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -1.24 |
| FCF Yield | 4.51 |
As of September 30, 2026, Alignment Healthcare, Inc. has an Altman Z-Score of 4.43, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.43 |